Other

Accrued liabilities

Roivant Sciences Accrued liabilities increased by 352.9% to $63.23M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2021 to FY 2023), Accrued liabilities shows a downward trend with a -10.9% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2020
Last reportedQ4 2025May 20, 2026

How to read this metric

Fluctuations reflect changes in the timing of operational expense recognition and payment cycles.

Detailed definition

This represents the net change in short-term obligations for expenses that have been incurred but not yet invoiced or pa...

Peer comparison

Standard line item in the operating section of the cash flow statement.

Metric ID: other_increase_decrease_in_accrued_liabilities

Historical Data

16 periods
 Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q3 '24Q1 '25Q4 '25
Value-$7.34M$25.91M$17.01M$15.02M-$18.18M$19.62M$4.26M$33.25M-$49.96M$37.57M-$3.40M$55.94M-$37.58M-$3.03M-$25.00M$63.23M
QoQ Change+453.0%-34.4%-11.7%-221.0%+208.0%-78.3%+681.5%-250.2%+175.2%-109.0%>999%-167.2%+91.9%-724.3%+352.9%
YoY Change-147.6%-24.3%-75.0%+121.4%-174.9%+91.4%-179.8%+68.2%+24.8%+10.7%+33.5%
Range-$49.96M$63.23M
CAGR+77.6%
Avg YoY Growth-22.9%
Median YoY Growth+10.7%

Frequently Asked Questions

What is Roivant Sciences's accrued liabilities?
Roivant Sciences (ROIV) reported accrued liabilities of $63.23M in Q1 2026.
What is the long-term trend for Roivant Sciences's accrued liabilities?
Over 2 years (2021 to 2023), Roivant Sciences's accrued liabilities has grown at a -10.9% compound annual growth rate (CAGR), from $50.60M to $40.15M.
What does accrued liabilities mean?
The net change in short-term obligations for expenses incurred but not yet paid.